skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi,
I am interested in your thoughts on these companies. EXAS and CRSP are a part of the recently fast moving ARKG ETF but both seem to offer products that would appear to offer continued growth. Would that be correct? The other two, VEEV and SGEN have been struggling price wise lately, SGEN is starting to see improvement, do you think VEEV still has good potential into the next year or two? I've also noticed more comments on Unity Software, but do not know much about it and it isn't listed in your data base. Take as many points as you need, as I'm asking multiple questions. Thanks for all your insight and suggestions, all very much appreciated!
Dawn
Read Answer Asked by Dawn on December 16, 2020
Q: I'm looking for your updated views on Inseego as it has been fairly flat since your last question in September. Their CEO was on Mad Money last week and I found the story he told to be compelling. I wonder if you could please describe what their position is within the market, who their main competitors are and what the total addressable market is as 5G gets rolling? Are we in the first or the fifth inning in terms of where INSG can run? At 1.5 billion in what I gather is a huge potential market it would be nice to know if you would rate it is a buy? Perhaps for good measure you can suggest if this has more or less room to run than Marvell and how they are different.

Thanks
Read Answer Asked by Tim on December 15, 2020
Q: Hello,
Regarding American companies, I am seeking recommendations for 2 long term hold positions. I have quite a high risk tolerance and prefer companies with a lot of room to grow. My current portfolio has relied heavily on FANG stocks and I am interested in consolidating those positions and redistributing to riskier but potentially more rewarding companies with good fundamentals.
Your insight is much appreciated.
Thank you.
Read Answer Asked by Lucas on December 15, 2020
Q: I am trying to understand Pfizer. In September it was trading at $36 and change. Today after all the good news about the vaccine it is at $39 and change. This seems like a small increase given the good it is doing and news, etc. However, if there were reports of a few bad reactions (or worse, sorry to say), the stock would tank. Can you help me understand this or maybe I am seeing it all wrong. Thanks again.
Read Answer Asked by Danny-boy on December 15, 2020
Q: Can you please rate these companies according to growth opportunities and another rating for risk? Thanks!
Read Answer Asked by Sandy on December 15, 2020
Q: Could I have your thoughts on BioHaven. It has a new drug for acute treatment of migraine headaches and seems to be very effective. Their stock has progressed since the drug was first put on the market earlier this year. How do they look financially? I believe they have an interest in another company Kleo Pharmaceuticals. I believe The Bill & Melinda Gates Foundation has also given Kleo a substantial grant.
Thanks John
Read Answer Asked by John on December 15, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!